Tanya Schild

862 total citations
9 papers, 313 citations indexed

About

Tanya Schild is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Tanya Schild has authored 9 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Tanya Schild's work include Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (2 papers) and Diet, Metabolism, and Disease (2 papers). Tanya Schild is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (2 papers) and Diet, Metabolism, and Disease (2 papers). Tanya Schild collaborates with scholars based in United States, Belgium and Sweden. Tanya Schild's co-authors include Vivien Low, John Blenis, Ana P. Gomes, John M. Asara, Bethany E. Schaffer, Lewis C. Cantley, Noah Dephoure, Stanislav Drápela, Didem Ilter and Melanie R. McReynolds and has published in prestigious journals such as Nature Communications, Molecular Cell and Cancer Cell.

In The Last Decade

Tanya Schild

9 papers receiving 312 citations

Peers

Countries citing papers authored by Tanya Schild

Since Specialization

Citations

This map shows the geographic impact of Tanya Schild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanya Schild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanya Schild more than expected).

Fields of papers citing papers by Tanya Schild

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanya Schild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanya Schild. The network helps show where Tanya Schild may publish in the future.

Co-authorship network of co-authors of Tanya Schild

This figure shows the co-authorship network connecting the top 25 collaborators of Tanya Schild. A scholar is included among the top collaborators of Tanya Schild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanya Schild. Tanya Schild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Metabolic engineering to facilitate anti-tumor immunity 2025 ·Cancer Cell ·Tanya Schild, (unknown), (unknown), Yating Wang, (unknown), Rachel Chirayil, (unknown), Kevin J. Chen, (unknown), Justin R. Cross, Elisa de Stanchina, Craig B. Thompson, David A. Scheinberg, Justin S. A. Perry, Kayvan R. Keshari	6
2	Abstract 3610: Utilizing fructose metabolism to fuel anti-tumor immunity 2024 ·Cancer Research ·Tanya Schild, Rachel Chirayil, (unknown), (unknown), Marjan Berishaj, David A. Scheinberg, Kayvan R. Keshari	1
3	NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis 2023 ·Redox Biology ·Didem Ilter, Stanislav Drápela, Tanya Schild, Nathan P. Ward, (unknown), Vivien Low, John M. Asara, Thórdur Óskarsson, Eric K. Lau, Gina M. DeNicola, Melanie R. McReynolds, Ana P. Gomes	21
4	Abstract 2890: Investigating dynamic IDO-Kyn-Ahr pathway induced tumor immunosuppression using imaging modality to optimize therapeutic Intervention 2023 ·Cancer Research ·(unknown), Inna Serganova, Sadna Budhu, Tanya Schild, (unknown), Kayvan R. Keshari, Jedd D. Wolchok, Taha Merghoub	1
5	Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression 2022 ·Nature Communications ·Zhongchi Li, Vivien Low, Valbona Luga, (unknown), Ethan M. Earlie, Bobak Parang, (unknown), Sungyun Cho, Jennifer E. Endress, Tanya Schild, Mengying Hu, David Lyden, Wen‐Bing Jin, Chun‐Jun Guo, Noah Dephoure, Lewis C. Cantley, Ashley M. Laughney, John Blenis	44
6	Altered propionate metabolism contributes to tumour progression and aggressiveness 2022 ·Nature Metabolism ·Ana P. Gomes, Didem Ilter, Vivien Low, Stanislav Drápela, Tanya Schild, Edouard Mullarky, Julie Han, Ilaria Elia, Dorien Broekaert, Adam Rosenzweig, Michal J. Nagiec, (unknown), Bethany E. Schaffer, Anders P. Mutvei, John M. Asara, Lewis C. Cantley, Sarah‐Maria Fendt, John Blenis	54
7	NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma 2021 ·Cell Reports ·Tanya Schild, Melanie R. McReynolds, (unknown), Vivien Low, Bethany E. Schaffer, John M. Asara, Elena Piskounova, Noah Dephoure, Joshua D. Rabinowitz, Ana P. Gomes, John Blenis	28
8	Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization 2018 ·Cancer Cell ·Tanya Schild, Vivien Low, John Blenis, Ana P. Gomes	132
9	Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma 2015 ·Molecular Cell ·Oren Litvin, Sarit Schwartz, (unknown), Tanya Schild, (unknown), (unknown), (unknown), Noël L. Goddard, Christine A. Pratilas, Dana Pe’er	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact